BeOne Medicines Ltd. (ONC): Cash & Equivalents
$4.55B
As of 2025-12-31
$5.10B
As of 2026-06-30
+5.5%
3-year compound annual growth
+26.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.55B | +73.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $2.63B | -17.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $3.17B | -18.0% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $3.87B | -11.6% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $4.38B | +216.6% | 2024-02-26, Balance as of period end |
| 2020-12-31 | $1.38B | +123.6% | 2023-02-27, Balance as of period end |
| 2019-12-31 | $618.01M | -13.3% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $712.94M | +197.6% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $239.60M | +173.8% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $87.51M | +389.8% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $17.87M | +28.6% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $13.90M | n/a | 2017-03-22, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.66B | +71.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.31B | +39.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | -8.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $282.03M | +155.1% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.31B | +10.8% |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗